Stock News

The Power of Small-Cap REITs Uncovering Hidden Gems in the Real Estate Investment Trust Market By Real Estate Expert Over my 15 years on Seeking Alpha, I’ve identified exceptional small-cap REITs like Ladder Capital and Whitestone Realty, yielding significant returns. These lesser-known companies have often been overlooked by investors, but they have proven to be…

Netflix’s Potential Growth with Ad-Supported Plans and Global Expansion Uncovering the Under-Appreciated Revenue Drivers Netflix’s upcoming Q3 2024 earnings announcement on October 17th has many investors and industry analysts buzzing with excitement. The streaming giant’s ad-supported plans and international growth are often overlooked but could be the key to driving revenue and profitability beyond expectations….

Pemvidutide: A Potential Game-changer in Obesity Treatment Introduction Pemvidutide, a novel GLP-1 agonist, has been gaining attention for its promising results in the treatment of obesity and metabolic syndrome (MASH). With a unique mechanism of action, pemvidutide has shown the ability to preserve lean mass while effectively reducing visceral adipose tissue (VAT), making it a…

Apple’s iPhone 16 Debut May Have Been Weak, But Don’t Count Them Out Yet: Why Now is the Perfect Time to Invest Description: I reiterate my buy rating for Apple Inc. despite recent price declines due to lower-than-expected iPhone 16 orders, citing long-term prospects and strong brand identity. The stock fell 3% due to lower…

Teva Pharmaceuticals Announces Positive Results for SOLARIS Trial New Hope for Patients with Schizophrenia In a groundbreaking announcement, Teva Pharmaceuticals revealed new positive efficacy, safety, and tolerability results for the Phase 3 Subcutaneous Olanzapine Extended-Release Injection Study (SOLARIS) trial, evaluating TEV-‘749 in adult patients diagnosed with schizophrenia. The study showed that TEV-‘749 met the primary…

The Impact of Luxury Stocks and the Boeing Strike on the Market Introduction In a recent episode of Barron’s Roundtable, associate editors Andrew Bary and Al Root, along with senior writer Elizabeth O’Brien, discussed various market topics, including the performance of luxury stocks and the implications of the Boeing strike. The conversation shed light on…

Reiterating my Buy Rating for FactSet Research Systems Positive Growth Outlook I am reiterating my buy rating for FactSet Research Systems due to the positive growth outlook driven by recent and expected Fed rate cuts. This strategic move by the Federal Reserve is expected to stimulate the economy and boost corporate earnings, which will ultimately…

Zions Bancorporation: A Closer Look Introduction Shares of Utah-based Zions Bancorporation have performed steadily over the past year, delivering a total return of approximately 40% which is on par with the broader regional bank industry. While Zions may not be considered a top-tier bank, it does have some positive attributes that make it an interesting…